Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels on neurons, limiting calcium entry and decreasing the release of excitatory neurotransmitters. This action dampens neuronal hyper‑excitability, which underlies both seizure activity and the transmission of neuropathic pain signals.

The specific dose of Neurontin is determined by the prescribing clinician based on the individual’s medical condition, age, renal function and response to therapy. Dosage regimens are personalized and should follow the prescriber’s instructions without deviation.

Safety data for gabapentin in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Neurontin. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with other anticonvulsants, gabapentin offers a distinct mechanism by targeting calcium channel subunits, which can be advantageous for patients who do not respond to sodium‑channel blockers. In neuropathic pain, it is often preferred for its favorable tolerability profile, though efficacy may vary among individuals and other agents such as pregabalin or duloxetine may be considered based on clinical response.

Neurontin should be stored at ambient temperature below 25 °C, protected from moisture and light. Keep the tablets in the original packaging until use, and avoid storing them in humid environments such as bathrooms or near heat sources.

Neurontin is taken orally, usually with or without food, as prescribed by the treating physician. The tablets are swallowed whole with a glass of water. Patients should follow the dosing schedule provided by their healthcare professional and not crush or split extended‑release formulations unless instructed.

Serious risks include suicidal thoughts or behavior, severe skin reactions such as Stevens‑Johnson syndrome, angioedema, respiratory depression (especially when combined with other CNS depressants), and rare hematologic abnormalities. Any sudden changes in mood, rash, swelling of the face or difficulty breathing should prompt immediate medical attention.

Neurontin is contraindicated in patients with known hypersensitivity to gabapentin or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those who are pregnant without a clear benefit. Clinicians should evaluate each patient’s medical history before initiating therapy.